Which has stronger valuation and earnings, TECH or BRKR?

Bio-Techne has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bio-Techne $1.22B 7.22 $73.40M $0.69 81.47 Bruker $3.46B 2.47 -$8.60M -$0.24 N/A

Is TECH or BRKR more profitable?

Bio-Techne has a net margin of 9.05% compared to Bruker's net margin of -0.65%. Bio-Techne's return on equity of 13.57% beat Bruker's return on equity. Company Net Margins Return on Equity Return on Assets Bio-Techne 9.05% 13.57% 10.66% Bruker -0.65% 11.60% 4.25%

Does the media prefer TECH or BRKR?

In the previous week, Bio-Techne had 1 more articles in the media than Bruker. MarketBeat recorded 9 mentions for Bio-Techne and 8 mentions for Bruker. Bruker's average media sentiment score of 1.11 beat Bio-Techne's score of 0.50 indicating that Bruker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 2 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BRKR or A?

In the previous week, Agilent Technologies had 6 more articles in the media than Bruker. MarketBeat recorded 14 mentions for Agilent Technologies and 8 mentions for Bruker. Agilent Technologies' average media sentiment score of 1.20 beat Bruker's score of 1.11 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 11 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, BRKR or IQV?

IQVIA has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than IQVIA, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bruker $3.46B 2.47 -$8.60M -$0.24 N/A IQVIA $16.31B 1.84 $1.36B $8.07 22.23

Is BRKR or IQV more profitable?

IQVIA has a net margin of 8.33% compared to Bruker's net margin of -0.65%. IQVIA's return on equity of 30.50% beat Bruker's return on equity. Company Net Margins Return on Equity Return on Assets Bruker -0.65% 11.60% 4.25% IQVIA 8.33% 30.50% 6.53%

Does the media refer more to BRKR or IQV?

In the previous week, IQVIA had 4 more articles in the media than Bruker. MarketBeat recorded 12 mentions for IQVIA and 8 mentions for Bruker. Bruker's average media sentiment score of 1.11 beat IQVIA's score of 0.98 indicating that Bruker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IQVIA 7 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BRKR or MTD?

In the previous week, Bruker had 7 more articles in the media than Mettler-Toledo International. MarketBeat recorded 8 mentions for Bruker and 1 mentions for Mettler-Toledo International. Bruker's average media sentiment score of 1.11 beat Mettler-Toledo International's score of 0.00 indicating that Bruker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, RVTY or BRKR?

Revvity has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Revvity $2.86B 3.99 $241.20M $2.09 48.89 Bruker $3.46B 2.47 -$8.60M -$0.24 N/A

Is RVTY or BRKR more profitable?

Revvity has a net margin of 8.26% compared to Bruker's net margin of -0.65%. Bruker's return on equity of 11.60% beat Revvity's return on equity. Company Net Margins Return on Equity Return on Assets Revvity 8.26% 8.00% 4.83% Bruker -0.65% 11.60% 4.25%

Does the media refer more to RVTY or BRKR?

In the previous week, Bruker had 6 more articles in the media than Revvity. MarketBeat recorded 8 mentions for Bruker and 2 mentions for Revvity. Bruker's average media sentiment score of 1.11 beat Revvity's score of 0.71 indicating that Bruker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revvity 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Bruker (BRKR) Competitors

$56.21 -0.42 (-0.75%)

As of 03:10 PM Eastern

Compare

BRKR vs. TECH, A, IQV, MTD, and RVTY

Should you buy Bruker stock or one of its competitors? MarketBeat compares Bruker with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bruker include Bio-Techne (TECH), Agilent Technologies (A), IQVIA (IQV), Mettler-Toledo International (MTD), and Revvity (RVTY).

How does Bruker compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Bruker (NASDAQ:BRKR) are both mid-cap life sciences tools & services companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

Bio-Techne has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	7.22	$73.40M	$0.69	81.47
Bruker	$3.46B	2.47	-$8.60M	-$0.24	N/A

Bio-Techne has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market. Comparatively, Bruker has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market.

Bio-Techne has a net margin of 9.05% compared to Bruker's net margin of -0.65%. Bio-Techne's return on equity of 13.57% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	9.05%	13.57%	10.66%
Bruker	-0.65%	11.60%	4.25%

Bio-Techne presently has a consensus target price of $65.15, suggesting a potential upside of 15.90%. Bruker has a consensus target price of $51.31, suggesting a potential downside of 8.71%. Given Bio-Techne's stronger consensus rating and higher probable upside, analysts plainly believe Bio-Techne is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	1 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.67
Bruker	2 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.40

In the previous week, Bio-Techne had 1 more articles in the media than Bruker. MarketBeat recorded 9 mentions for Bio-Techne and 8 mentions for Bruker. Bruker's average media sentiment score of 1.11 beat Bio-Techne's score of 0.50 indicating that Bruker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	2 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bruker	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by insiders. Comparatively, 27.2% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.6%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.4%. Bio-Techne pays out 46.4% of its earnings in the form of a dividend. Bruker pays out -83.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Bio-Techne beats Bruker on 14 of the 18 factors compared between the two stocks.

How does Bruker compare to Agilent Technologies?

Bruker (NASDAQ:BRKR) and Agilent Technologies (NYSE:A) are both life sciences tools & services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

Bruker currently has a consensus price target of $51.31, indicating a potential downside of 8.71%. Agilent Technologies has a consensus price target of $160.93, indicating a potential upside of 24.35%. Given Agilent Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Agilent Technologies is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	2 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.40
Agilent Technologies	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88

Agilent Technologies has a net margin of 19.55% compared to Bruker's net margin of -0.65%. Agilent Technologies' return on equity of 24.33% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	-0.65%	11.60%	4.25%
Agilent Technologies	19.55%	24.33%	12.99%

In the previous week, Agilent Technologies had 6 more articles in the media than Bruker. MarketBeat recorded 14 mentions for Agilent Technologies and 8 mentions for Bruker. Agilent Technologies' average media sentiment score of 1.20 beat Bruker's score of 1.11 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilent Technologies	11 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilent Technologies has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.46B	2.47	-$8.60M	-$0.24	N/A
Agilent Technologies	$6.95B	5.26	$1.30B	$4.98	25.99

Bruker has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Agilent Technologies has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.

Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.4%. Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.8%. Bruker pays out -83.3% of its earnings in the form of a dividend. Agilent Technologies pays out 20.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has raised its dividend for 9 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

79.5% of Bruker shares are held by institutional investors. 27.2% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Agilent Technologies beats Bruker on 15 of the 19 factors compared between the two stocks.

How does Bruker compare to IQVIA?

Bruker (NASDAQ:BRKR) and IQVIA (NYSE:IQV) are related companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Bruker currently has a consensus price target of $51.31, suggesting a potential downside of 8.71%. IQVIA has a consensus price target of $224.13, suggesting a potential upside of 24.94%. Given IQVIA's stronger consensus rating and higher probable upside, analysts clearly believe IQVIA is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	2 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.40
IQVIA	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	3.00

IQVIA has a net margin of 8.33% compared to Bruker's net margin of -0.65%. IQVIA's return on equity of 30.50% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	-0.65%	11.60%	4.25%
IQVIA	8.33%	30.50%	6.53%

Bruker has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

In the previous week, IQVIA had 4 more articles in the media than Bruker. MarketBeat recorded 12 mentions for IQVIA and 8 mentions for Bruker. Bruker's average media sentiment score of 1.11 beat IQVIA's score of 0.98 indicating that Bruker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IQVIA	7 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

79.5% of Bruker shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 27.2% of Bruker shares are owned by insiders. Comparatively, 1.7% of IQVIA shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

IQVIA has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than IQVIA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.46B	2.47	-$8.60M	-$0.24	N/A
IQVIA	$16.31B	1.84	$1.36B	$8.07	22.23

Summary

IQVIA beats Bruker on 13 of the 17 factors compared between the two stocks.

How does Bruker compare to Mettler-Toledo International?

Bruker (NASDAQ:BRKR) and Mettler-Toledo International (NYSE:MTD) are both life sciences tools & services companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

In the previous week, Bruker had 7 more articles in the media than Mettler-Toledo International. MarketBeat recorded 8 mentions for Bruker and 1 mentions for Mettler-Toledo International. Bruker's average media sentiment score of 1.11 beat Mettler-Toledo International's score of 0.00 indicating that Bruker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Bruker has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.46B	2.47	-$8.60M	-$0.24	N/A
Mettler-Toledo International	$4.03B	5.81	$869.19M	$42.64	27.13

Bruker presently has a consensus price target of $51.31, suggesting a potential downside of 8.71%. Mettler-Toledo International has a consensus price target of $1,408.55, suggesting a potential upside of 21.75%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, analysts plainly believe Mettler-Toledo International is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	2 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.40
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Mettler-Toledo International has a net margin of 21.40% compared to Bruker's net margin of -0.65%. Bruker's return on equity of 11.60% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	-0.65%	11.60%	4.25%
Mettler-Toledo International	21.40%	-622.80%	24.97%

79.5% of Bruker shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 27.2% of Bruker shares are owned by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Mettler-Toledo International beats Bruker on 10 of the 16 factors compared between the two stocks.

How does Bruker compare to Revvity?

Revvity (NYSE:RVTY) and Bruker (NASDAQ:BRKR) are related companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

Revvity currently has a consensus price target of $107.73, indicating a potential upside of 5.43%. Bruker has a consensus price target of $51.31, indicating a potential downside of 8.71%. Given Revvity's higher possible upside, equities research analysts clearly believe Revvity is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revvity	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21
Bruker	2 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.40

Revvity has a net margin of 8.26% compared to Bruker's net margin of -0.65%. Bruker's return on equity of 11.60% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Revvity	8.26%	8.00%	4.83%
Bruker	-0.65%	11.60%	4.25%

In the previous week, Bruker had 6 more articles in the media than Revvity. MarketBeat recorded 8 mentions for Bruker and 2 mentions for Revvity. Bruker's average media sentiment score of 1.11 beat Revvity's score of 0.71 indicating that Bruker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Revvity	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bruker	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

86.7% of Revvity shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.9% of Revvity shares are owned by company insiders. Comparatively, 27.2% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.4%. Revvity pays out 13.4% of its earnings in the form of a dividend. Bruker pays out -83.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bruker is clearly the better dividend stock, given its higher yield and lower payout ratio.

Revvity has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revvity	$2.86B	3.99	$241.20M	$2.09	48.89
Bruker	$3.46B	2.47	-$8.60M	-$0.24	N/A

Revvity has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, Bruker has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market.

Summary

Bruker beats Revvity on 11 of the 19 factors compared between the two stocks.

Get Bruker News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BRKR vs. The Competition

Export

Metric	Bruker	INSTRU Industry	Computer Sector	NASDAQ Exchange
Market Cap	$8.57B	$1.46B	$39.55B	$12.25B
Dividend Yield	0.37%	0.37%	3.16%	5.66%
P/E Ratio	-234.46	3.39	80.72	24.45
Price / Sales	2.47	1.36	630.54	138.35
Price / Cash	16.07	7.20	49.02	37.92
Price / Book	3.45	2.99	9.92	6.77
Net Income	-$8.60M	-$9.28M	$1.07B	$337.21M
7 Day Performance	-1.81%	-3.16%	1.45%	2.12%
1 Month Performance	31.08%	0.50%	6.39%	3.99%
1 Year Performance	43.82%	-4.86%	159.40%	28.92%

Bruker Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BRKR Bruker	2.6903 of 5 stars	$56.21 -0.7%	$51.31 -8.7%	+47.9%	$8.57B	$3.46B	N/A	11,085	News Coverage Positive News
TECH Bio-Techne	3.5132 of 5 stars	$52.65 +1.3%	$65.17 +23.8%	+11.2%	$8.14B	$1.22B	76.31	3,100	News Coverage
A Agilent Technologies	4.9701 of 5 stars	$132.88 -1.9%	$161.71 +21.7%	+11.6%	$38.25B	$6.95B	26.68	18,100	Positive News
IQV IQVIA	4.5218 of 5 stars	$183.64 +0.1%	$224.13 +22.0%	+13.7%	$30.62B	$16.31B	22.76	93,000	Analyst Upgrade
MTD Mettler-Toledo International	3.473 of 5 stars	$1,139.04 -1.3%	$1,408.55 +23.7%	+0.1%	$23.33B	$4.03B	26.71	18,100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BRKR) was last updated on 6/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bruker (BRKR) Competitors